###begin article-title 0
###xml 75 107 <span type="species:ncbi:11216">human parainfluenza virus type 3</span>
Retinoic acid inducible gene I Activates innate antiviral response against human parainfluenza virus type 3
###end article-title 0
###begin p 1
###xml 0 32 <span type="species:ncbi:11216">Human parainfluenza virus type 3</span>
###xml 137 144 <span type="species:ncbi:9606">infants</span>
###xml 149 157 <span type="species:ncbi:9606">children</span>
Human parainfluenza virus type 3 (HPIV3) is a respiratory paramyxovirus that infects lung epithelial cells to cause high morbidity among infants and children. To date, no effective vaccine or antiviral therapy exists for HPIV3 and therefore, it is important to study innate immune antiviral response induced by this virus in infected cells. Type-I interferons (IFN, interferon-alpha/beta) and tumor necrosis factor-alpha (TNFalpha activated by NFkappaB) are potent antiviral cytokines that play an important role during innate immune antiviral response. A wide-spectrum of viruses utilizes pattern recognition receptors (PRRs) like toll-like receptors (TLRs) and RLH (RIG like helicases) receptors such as RIGI (retinoic acid inducible gene -I) and Mda5 to induce innate antiviral response. Previously it was shown that both TNFalpha and IFNbeta are produced from HPIV3 infected cells. However, the mechanism by which infected cells activated innate response following HPIV3 infection was not known. In the current study, we demonstrated that RIGI serves as a PRR in HPIV3 infected cells to induce innate antiviral response by expressing IFNbeta (via activation of interferon regulatory factor-3 or IRF3) and TNFalpha (via activation of NF-kappaB).
###end p 1
###begin title 2
Findings
###end title 2
###begin p 3
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1012 1013 1008 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1228 1229 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1230 1231 1219 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1465 1466 1447 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1467 1468 1449 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1820 1821 1790 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1822 1824 1792 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 0 32 <span type="species:ncbi:11216">Human parainfluenza virus type 3</span>
###xml 273 280 <span type="species:ncbi:9606">infants</span>
###xml 282 290 <span type="species:ncbi:9606">children</span>
###xml 1647 1680 <span type="species:ncbi:11250">human respiratory syncytial virus</span>
###xml 1682 1685 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Human parainfluenza virus type 3 (HPIV3) is an enveloped non-segmented negative-sense single stranded (NNS) RNA virus that belongs to the paramyxovirus family [1]. HPIV3 is a lung tropic virus known to cause severe respiratory diseases (croup, bronchiolitis, pneumonia) in infants, children, elderly and immuno-comprimised individuals [1,2]. Although HPIV3 causes life-threatening respiratory tract diseases, currently no effective vaccine or antiviral therapy exists. Therefore, elucidation of innate immune antiviral response induced by HPIV3 holds significant potential for development of effective antiviral therapies in the near future. The innate immune antiviral response against viruses represents an important host defense mechanism [3]. Innate immunity comprises the first line of defense by the host to combat virus infection before an orchestrated adaptive immune response is launched. Two key molecules regulating the innate antiviral function are interferon regulatory factors (IRFs) and NFkappaB [3]. These two transcription factors are activated either individually or together in infected cells, resulting in the expression and production of potent antiviral cytokines IFN-alpha/beta (IFN) (type I interferon) [4,5]. IFNalpha/beta produced from infected cells binds to their cognate IFN receptors on uninfected cells to induce the JAK/STAT antiviral pathway. Thus the paracrine action of IFN is absolutely critical during innate antiviral defense [4-8]. Although the paracrine action of IFNs plays a critical role in innate immune antiviral response, we have also identified an IFN independent antiviral pathway against HPIV3 and human respiratory syncytial virus (RSV) that was dependent on NF-kappaB activation and production of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNFalpha) [9,10].
###end p 3
###begin p 4
###xml 304 306 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 393 395 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 494 496 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 617 619 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 844 846 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1110 1112 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 590 593 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 598 615 <span type="species:ncbi:11320">influenza A virus</span>
Infected cells utilize pattern recognition receptors (PRRs) to recognize pathogen (virus) associated molecular patterns (PAMPs) to trigger activation of the transcription factors IRF3 and NF-kappaB, which then translocate to the nucleus to transactivate antiviral genes like IFNalpha/beta, TNFalpha etc [11]. So far two classes of viral PRRs have been identified - toll-like receptors (TLRs) [12] and RLH (RIG like helicases) receptors such as RIGI (retinoic acid inducible gene - I) and Mda5 [13]. Recently, we also demonstrated that NOD-like receptors such as NOD2 could act as a PRR for RSV and influenza A virus [14]. TLRs are type I integral transmembrane proteins that are utilized by various viruses to activate NFkappaB and IRF3 in infected cells. Majority of TLRs require MyD88 as an adaptor protein to induce TLR-dependent signaling [12]. In contrast to membrane bound TLR proteins, RLH receptors are cytoplasmic PRRs. Both RIGI and Mda5 signals antiviral response via induction of IRF3 and NFkappaB pathways after binding to the single stranded RNA genome of paramyxo, orthomyxo and picarnoviruses [13]. Although TLRs and RLH receptors were shown to induce innate antiviral response following infection with various RNA and DNA viruses, the mechanism by which HPIV3 activates the innate response is not known. Moreover, there are no reports of any PRR that play an important role in activation of IRF3/NF-kappaB during HPIV3 infection.
###end p 4
###begin p 5
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 313 314 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 814 816 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 674 679 <span type="species:ncbi:9606">human</span>
###xml 709 712 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 799 802 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 865 868 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 1010 1015 <span type="species:ncbi:9606">human</span>
The innate immune response to HPIV3 is not well understood. HPIV3 has been shown to produce IFN-I in vivo and in vitro [15-17] yet no reports of IRF3 activation by HPIV3 exist. In addition, previous studies have demonstrated that HPIV3 activates NFkappaB to produce TNFalpha for establishment of antiviral state [9]. Moreover, TLRs may be involved in NFkappaB activation (at 24 h post-infection) since blocking MyD88 function diminished NF-kappaB activation in HPIV3 infected cells by 50%-55%. This suggested that both TLRs and non-TLR molecules may be involved in NFkappaB activation in HPIV3 infected cells. A similar scenario has been reported for another paramyxovirus, human respiratory syncitial virus (RSV). It was shown that both TLR3 and RIGI are involved in NF-kappaB activation following RSV infection [18]. Therefore, we investigated whether similar to RSV; HPIV3 can also utilize RIGI to activate innate antiviral response. In the current studies we have demonstrated that in A549 (A549 cells are human respiratory epithelial cells that have been routinely used as a model of type II alveolar epithelial cells) cells RIGI plays an important role in activation of innate antiviral response during HPIV3 infection. Moreover, RIGI was involved in activating both arms (NFkappaB/TNFalpha and IRF3/IFNalpha/beta) of innate immunity following HPIV3 infection.
###end p 5
###begin p 6
###xml 598 599 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 600 602 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 756 758 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 779 781 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 1129 1146 1113 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH forward, 5'</italic>
###xml 1169 1186 1153 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH reverse, 5'</italic>
###xml 1209 1226 1193 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG15 forward, 5'</italic>
###xml 1246 1263 1230 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ISG15 reverse, 5'</italic>
###xml 1283 1303 1267 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#946; forward, 5'</italic>
###xml 1327 1343 1308 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#946; reverse</italic>
###xml 1369 1386 1347 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; forward</italic>
###xml 1421 1438 1395 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-&#945; reverse</italic>
###xml 1597 1603 1564 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C, 1D</xref>
In order to study the involvement of RIGI in antiviral response stimulation via activation of IRF3/NFkappaB, we expressed RIGI (FLAG tagged) in 293 cells (these cells does not express majority of endogenous PRRs) and analyzed IFN/NFkappaB activation following HPIV3 infection. For these experiments, 293 cells were transfected (by using lipofectamine 2000 from Invitrogen) with FLAG-RIGI, pcDNA, NF-kappaB-luciferase, and IRF3-luciferase plasmids. At 24 h post-trasfection, cells were infected with HPIV-3 (0.5 MOI) and luciferase assay was performed at 8 h post-infection as described previously [9,14]. The efficiency of RIGI expression was confirmed by Western blotting (with FLAG antibody) of lysate obtained from RIGI-FLAG transfected 293 cells (Fig. 1A). As shown, in Fig. 1B, RIGI expression resulted in drastic activation (measured by luciferase assay) of both NF-kappaB and IRF3 in HPIV3 infected cells. The role of RIGI in activation of these transcription factors were further confirmed by detecting expression [reverse transcription or RT-PCR was performed using RedMIX Plus (Gene Choice) with the following primers: GAPDH forward, 5'-GTCAGTGGTGGACCTGACCT, GAPDH reverse, 5'-AGGGGTCTACATGGCAACTG; ISG15 forward, 5'-CCGTGAAGATGCTGGCG, ISG15 reverse, 5'-CGAAGGTCAGCCAGAAC; IFN-beta forward, 5'-GATTCATCTAGCACTGGCTGG, IFN-beta reverse, 5'CTTCAGGTAATGCAGAATCC; TNF-alpha forward, GAGTGACAAGCCTGTAGCCCATGTTGTAGCA, TNF-alpha reverse, GCAATGATCCCAAAGTAGACCTGCCCAGACT] of their target genes, TNF, IFN-beta and ISG-15 (interferon stimulated gene-15) in infected 293 cells expressing RIGI (Fig. 1C, 1D). These results demonstrated that RIGI is capable of activating an innate antiviral response in HPIV3 infected cells.
###end p 6
###begin p 7
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Activation of antiviral response by RIGI during HPIV3 infection</bold>
###xml 65 69 65 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 205 209 205 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
###xml 474 478 468 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c) </bold>
###xml 686 690 677 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(d) </bold>
Activation of antiviral response by RIGI during HPIV3 infection. (a) Western blot analysis (with anti-FLAG antibody) of RIGI expression in 293 cells transfected with pcDNA and RIGI (FLAG tagged) plasmids. (b) Activation of IRF3-luciferase and NF-kappaB-luciferase in mock and HPIV3 infected (at 8 h post-infection) 293 cells transfected with either pcDNA or RIGI. The luciferase assay results are presented as mean +/- standard deviation from three independent experiments. (c) RT-PCR analysis of TNF and IFN-beta expression (at 4 h and 8 h post-infection) in mock and HPIV3 infected 293 cells transfected with either pcDNA or RIGI. GAPDH served as a loading control. NS; non-specific. (d) RT-PCR analysis of ISG-15 expression (at 2 h, 4 h and 8 h post-infection) in mock and HPIV3 infected 293 cells transfected with either pcDNA or RIGI
###end p 7
###begin p 8
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 344 346 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 806 808 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2B</xref>
RIGI protein consists of helicase and two CARD (caspase recruitment domain) domains (Fig. 2A) domains. Previous studies have shown that CARD domains are required for RIGI mediated signal transduction [19]; which constitutes interaction of RIGI with the mitochondrial localized adaptor protein MAVS (IPS-1) and activation of IRF3 and NF-kappaB [18]. In order to investigate the role of caspase domains in antiviral signaling, we co-expressed FLAG tagged wild type (WT) and CARD deleted RIGI (DeltaRIGI) in 293 cells, followed by HPIV3 infection. At 8 h post-infection, TNF and IFN-beta induction was measured by RT-PCR. Our result revealed that CARD domains are critical for antiviral signaling, since co-expression of WT and DeltaRIGI resulted in loss of IFN-beta and TNF induction in infected cells (Fig. 2B). These results demonstrated that CARD domains are important for RIGI signaling during HPIV3 infection. Furthermore, RIGI lacking the CARD domains (i.e. DeltaRIGI) can act as a dominant negative molecule to suppress the activity of functional RIGI during HPIV3 infection.
###end p 8
###begin p 9
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD domains of RIGI are important for activation of antiviral response</bold>
###xml 73 77 73 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 192 196 188 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
CARD domains of RIGI are important for activation of antiviral response. (a) A schematic showing the RIGI constructs; WT RIGI (wild type RIGI)), DeltaRIGI (RIGI lacking the two CARD domains). (b) RT-PCR analysis of TNF and IFN-beta expression (at 8 h post-infection) in mock and HPIV3 infected 293 cells transfected with the indicated plasmids. GAPDH served as a loading control.
###end p 9
###begin p 10
###xml 282 298 278 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIGI forward, 5'</italic>
###xml 322 338 318 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RIGI reverse, 5'</italic>
###xml 440 442 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 658 660 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 998 999 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1192 1194 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 1573 1575 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D</xref>
###xml 1695 1697 1635 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3E</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 1853 1858 <span type="species:ncbi:9606">human</span>
Since HPIV3 is a respiratory virus, we next evaluated the role of RIGI in inducing IRF3/NF-kappaB in infected human lung epithelial A549 cells. Infection of A549 cells with HPIV3 resulted in induction of endogenous RIGI expression (RT-PCR was performed using the following primers: RIGI forward, 5'-GCATATTGACTGGACGTGGCA, RIGI reverse, 5'-CAGTCATGGCTGCAGTTCTGTC) during relatively early infection time frame (8 h-12 h post-infection) (Fig. 3A). Similarly, IRF3 and NF-kappaB (as assessed by luciferase assay of infected A549 cells transfected with IRF3 and NF-kappaB luciferase) was induced by HPIV3 during early infection (within 12 h post-infection) (Fig. 3B). Based on similar induction/activation kinetics of RIGI and IRF3/NF-kappaB, we speculated that endogenous RIGI may play a role during IRF3/NF-kappaB activation. To examine such role of RIGI, we initially utilized A549 cells expressing (following transfection) DeltaRIGI-FLAG, since DeltaRIGI acted as a dominant-negative molecule (Fig. 2). Efficient expression of DeltaRIGI (denoted as dominant negative RIGI or DN-RIGI) is evident from the Western blotting of A549 cell lysate with FLAG antibody (to detect DeltaRIGI-FLAG) (Fig. 3C). In order to investigate the involvement of RIGI, A549 cells were transfected with DeltaRIGI-FLAG, NF-kappaB- or IRF3-luciferase. At 24 h post-transfection, cells were infected with HPIV3 and luciferase activity was measured at 12 h post-infection. Expression of DeltaRIGI in A549 resulted in drastic decline in both NF-kappaB and IRF3 activity following HPIV3 infection (Fig. 3D). In addition, infected cells expressing DeltaRIGI lost expression of IRF3/NF-kappaB target genes TNF and ISG-15 (Fig. 3E). These results demonstrated that endogenously expressed RIGI plays a crucial role in activation of innate antiviral response following HPIV3 infection of human lung epithelial cells.
###end p 10
###begin p 11
###xml 0 119 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inactivation of endogenous RIGI in A549 cells by dominant-negative RIGI (&#916;RIGI) abrogates innate antiviral response</bold>
###xml 121 125 117 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 228 232 224 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
###xml 461 465 451 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c) </bold>
###xml 661 665 651 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(d) </bold>
###xml 934 938 918 922 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(e) </bold>
Inactivation of endogenous RIGI in A549 cells by dominant-negative RIGI (DeltaRIGI) abrogates innate antiviral response. (a) RT-PCR analysis of endogenous RIGI expression in HPIV3 infected (at 4 h-12 post-infection) A549 cells. (b) Activation of IRF3-luciferase and NF-kappaB-luciferase in mock and HPIV3 infected (at 12 h post-infection) A549 cells. The luciferase assay results are presented as mean +/- standard deviation from three independent experiments. (c) Expression of FLAG tagged dominant-negative RIGI (DN-RIGI) in A549 cells was assessed by Western blotting A549 cell (transfected with either pcDNA or FLAG-DN-RIGI) lysate with anti-FLAG antibody. (d) Activation of IRF3-luciferase and NFkappa-B-luciferase in mock and HPIV3 infected (at 12 h post-infection) A549 cells trasfected with either pcDNA or DN-RIGI. The luciferase assay results are presented as mean +/- standard deviation from three independent experiments. (e) RT-PCR analysis of TNF and ISG-15 expression (at 12 h and 16 h post-infection) in mock and HPIV3 infected A549 cells transfected with either pcDNA or DN-RIGI.
###end p 11
###begin p 12
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 882 884 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 1007 1012 <span type="species:ncbi:9606">human</span>
The role of endogenous RIGI was further confirmed by silencing RIGI expression in A549 cells. The silencing was performed by transfecting A549 cells with control or RIGI specific siRNA [negative control siRNA and DDX58-1 (RIG-I) siRNA were ordered from Qiagen and cells were transfected with 80 nM of siRNA using lipofectamine 2000]. The efficiency of silencing was validated in A549 cells, since HPIV3 failed to induce RIGI expression in cells expressing RIGI-specific siRNA (Fig. 4A). We next utilized the RIGI silenced A549 cells to examine the role of RIGI. Analysis of TNF gene expression by RT-PCR revealed failure of HPIV3 to optimally induce TNF in RIGI silenced cells, compared to cells transfected with control siRNA (Fig. 4B). Similarly, expression of IFN-beta following HPIV-3 infection was drastically reduced in the absence of RIGI (RIGI silenced cells) protein (Fig. 4C). These results demonstrated an involvement of endogenous RIGI in inducing the innate antiviral pathway in HPIV3 infected human lung cells.
###end p 12
###begin p 13
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Silencing of endogenous RIGI in A549 cells results in loss of induction of antiviral response</bold>
###xml 95 99 95 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 259 263 259 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
###xml 422 426 422 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(c) </bold>
Silencing of endogenous RIGI in A549 cells results in loss of induction of antiviral response. (a) RT-PCR analysis of RIGI expression in mock and HPIV3 infected (at 12 h post-infection) A549 cells transfected with either control siRNA or RIGI specific siRNA. (b) RT-PCR analysis of TNF expression in mock and HPIV3 infected (at 12 h post-infection) A549 cells transfected with either control siRNA or RIGI specific siRNA. (c) RT-PCR analysis of IFN-beta expression in mock and HPIV3 infected (at 12 h post-infection) A549 cells transfected with either control siRNA (Con siRNA) or RIGI specific siRNA (RIGI siRNA).
###end p 13
###begin p 14
###xml 629 631 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 967 969 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1180 1182 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1183 1185 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1267 1269 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1270 1272 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1404 1406 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 923 935 <span type="species:ncbi:11191">Sendai virus</span>
###xml 939 944 <span type="species:ncbi:10090">mouse</span>
###xml 1340 1352 <span type="species:ncbi:11191">Sendai virus</span>
###xml 1356 1361 <span type="species:ncbi:10090">mouse</span>
Our results have demonstrated a role of RIGI as a HPIV3 specific PRR involved in inducing innate antiviral response following activation of IRF3/IFN and NF-kappaB/TNF. However, additional non-RIGI PRRs may also be involved in inducing innate response following HPIV3 infection. In that context, well-established PRRs like Mda5, TLR3 and TLR7 that are known to recognize viruses and single-stranded RNA (ssRNA) are not involved during innate response by HPIV3 infected lung epithelial cells. Mda5 has previously been shown to specifically recognize positive-sense single-stranded RNA viruses like picornaviruses and alphaviruses [13]. Moreover, expression of TLR3 in 293 cells did not result in induction of IRF3 and NF-kappaB activity following HPIV3 infection (data not shown). Our observation is similar to previous studies showing the non-involvement of TLR3 during induction of innate response following infection with Sendai virus (a mouse parainfluenza virus) [20]. TLR7 (which is capable of recognizing ssRNA) also do not function as HPIV3 specific PRR in lung cells since, a) A549 cells (the lung epithelial cells utilized in our current studies) lack expression of TLR7 [21-23], b) TLR7 activating compound (e.g. R848) failed to activate TLR7 in A549 cells [22,23], and c) TLR7 is not required for IRF3 and NF-kappaB activation in Sendai virus (a mouse parainfluenza virus) infected A549 cells [21]. Our future studies will be directed in identifying and characterizing additional PRRs that may play a role in activating innate response following HPIV3 infection.
###end p 14
###begin title 15
Abbreviations
###end title 15
###begin p 16
###xml 7 39 <span type="species:ncbi:11216">human parainfluenza virus type 3</span>
HPIV3: human parainfluenza virus type 3; RIGI: retinoic acid inducible gene-I; TNF: tumor necrosis factor-alpha; IFN: interferon; ISG15: interferon stimulated gene-15; IRF3: interferon regulatory factor 3.
###end p 16
###begin title 17
Competing interests
###end title 17
###begin p 18
The authors declare that they have no competing interests.
###end p 18
###begin title 19
Authors' contributions
###end title 19
###begin p 20
AS and SB designed the experiments and prepared the manuscript. AS performed the experiments. All authors read and approved the final manuscript.
###end p 20
###begin title 21
Acknowledgements
###end title 21
###begin p 22
This work was supported by National Institutes of Health grants AI069062 (to SB), CA129246 (to SB), American Lung Association National Biomedical Research Grant-RG-49629-N (to SB). AS is supported by National Institutes of Health training grant T32-DE14318 (COSTAR program). We would like to thanks Dr. Kui Li (University of Tennessee Health Science Center) and Dr. Adolfo Garcia-Sastre (Mt. Sinai School of Medicine, New York, NY) for providing several reagents used in the study.
###end p 22
###begin article-title 23
Parainfluenza viruses
###end article-title 23
###begin article-title 24
###xml 0 27 <span type="species:ncbi:12814">Respiratory syncytial virus</span>
Respiratory syncytial virus and parainfluenza virus
###end article-title 24
###begin article-title 25
Innate immune response against nonsegmented negative strand RNA viruses
###end article-title 25
###begin article-title 26
How cells respond to interferons
###end article-title 26
###begin article-title 27
Interferons and other cytokines
###end article-title 27
###begin article-title 28
Phospholipid scramblase 1 potentiates the antiviral activity of interferon
###end article-title 28
###begin article-title 29
###xml 14 40 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins
###end article-title 29
###begin article-title 30
Impaired nitric oxide synthase (NOS) 2 signaling pathway in cystic fibrosis airway epithelium
###end article-title 30
###begin article-title 31
Temporal activation of NF-kB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses
###end article-title 31
###begin article-title 32
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 119 152 <span type="species:ncbi:11250">human respiratory syncytial virus</span>
Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB mediated innate anti-viral response against human respiratory syncytial virus
###end article-title 32
###begin article-title 33
Toll-like receptors and Type I interferons
###end article-title 33
###begin article-title 34
How Toll-like receptors signal: what we know and what we don't know
###end article-title 34
###begin article-title 35
Sensing RNA virus infections
###end article-title 35
###begin article-title 36
Activation of innate immune antiviral response by NOD2
###end article-title 36
###begin article-title 37
###xml 32 64 <span type="species:ncbi:11216">human parainfluenza virus type 3</span>
Interferon type I downregulates human parainfluenza virus type 3-induced major histocompatibility complex class II expression
###end article-title 37
###begin article-title 38
Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro
###end article-title 38
###begin article-title 39
###xml 93 119 <span type="species:ncbi:11216">parainfluenza virus type 3</span>
Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3
###end article-title 39
###begin article-title 40
###xml 104 131 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells
###end article-title 40
###begin article-title 41
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
###end article-title 41
###begin article-title 42
###xml 29 41 <span type="species:ncbi:11191">Sendai virus</span>
Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3
###end article-title 42
###begin article-title 43
Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner
###end article-title 43
###begin article-title 44
###xml 37 54 <span type="species:ncbi:11320">influenza A virus</span>
Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression
###end article-title 44
###begin article-title 45
###xml 66 71 <span type="species:ncbi:9606">human</span>
IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression
###end article-title 45

